DSpace Repository

Comment: Management of De Novo Chronic Myelogenous Leukemia and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation Tyrosine Kinase Inhibitor Dasatinib

Show simple item record

dc.contributor.author Uz, Burak
dc.contributor.author Dolasik, Ilhan
dc.date.accessioned 2019-09-17T10:15:25Z
dc.date.available 2019-09-17T10:15:25Z
dc.date.issued 2016
dc.identifier.citation Uz, B. Dolasik, I . (2016). Comment: Management of De Novo Chronic Myelogenous Leukemia and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation Tyrosine Kinase Inhibitor Dasatinib. Cilt:50. Sayı:4. 334- 335 ss. tr_TR
dc.identifier.uri http://hdl.handle.net/11616/14101
dc.language.iso eng tr_TR
dc.publisher Sage publıcatıons ınc, 2455 teller rd, thousand oaks, ca 91320 usa tr_TR
dc.relation.isversionof 10.1177/1060028015627663 tr_TR
dc.rights info:eu-repo/semantics/restrictedAccess tr_TR
dc.title Comment: Management of De Novo Chronic Myelogenous Leukemia and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation Tyrosine Kinase Inhibitor Dasatinib tr_TR
dc.type article tr_TR
dc.relation.journal Annals of pharmacotherapy tr_TR
dc.contributor.department İnönü Üniversitesi tr_TR
dc.identifier.volume 50 tr_TR
dc.identifier.issue 4 tr_TR
dc.identifier.startpage 334 tr_TR
dc.identifier.endpage 335 tr_TR


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record